{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T13:48:47Z","timestamp":1760622527292,"version":"3.32.0"},"reference-count":51,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,6,30]],"date-time":"2006-06-30T00:00:00Z","timestamp":1151625600000},"content-version":"vor","delay-in-days":29,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[2006,6]]},"abstract":"<jats:p><jats:bold><jats:sc>Abstract:\u2002<\/jats:sc><\/jats:bold><jats:bold>The main pathologic hallmark of systemic sclerosis (SSc) is endothelial derangement; the pathologic alterations of the vessel wall in SSc are strikingly similar to the modification detected in the atherosclerotic lesions, and it is now evident that SSc is also characterized by accelerated macrovascular disease. Peptides related to angiotensin II, the final product of the renin\u2013angiotensin system (RAS), play a role as regulators of endothelial cell function. Angiotensin\u2010converting enzyme (ACE), the key enzyme in the RAS, is the predominant pathway of angiotensin II formation in blood and tissues. In intron 16 of the gene encoding for ACE an insertion\/deletion (I\/D) polymorphism, consisting of the presence or absence of a 287\u2013base pair Alu sequence, has been identified. This polymorphism has been related to ACE enzyme levels, and data from experimental studies reported a functional role for this polymorphism in modulating the angiotensin II levels. We previously documented a high ACE D allele frequency in SSc patients and its role in increasing the risk of SSc, thus suggesting that the I\/D polymorphism might be a useful genetic marker to identify SSc patients at risk to develop a severe vascular disease, frequently leading to gangrene. Moreover, our preliminary data, besides supporting the role of ACE I\/D polymorphism as a predisposing factor to SSc, demonstrated its involvement in accelerated macrovascular disease by increasing the intima media thickness. Therefore, in SSc, not only endothelial dysfunction, but also vascular damage, linked to ACE I\/D polymorphism, may significantly contribute to accelerated macrovascular disease, as the ACE D allele, by regulating both the production of angiotensin II and the degradation of bradykinin, contributes to mechanisms involved in the induction and maintenance of vessel wall modification.<\/jats:bold><\/jats:p>","DOI":"10.1196\/annals.1351.002","type":"journal-article","created":{"date-parts":[[2006,7,19]],"date-time":"2006-07-19T19:35:49Z","timestamp":1153337749000},"page":"10-19","source":"Crossref","is-referenced-by-count":9,"title":["Angiotensin\u2010Converting Enzyme in Systemic Sclerosis"],"prefix":"10.1111","volume":"1069","author":[{"given":"SERENA","family":"GUIDUCCI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CINZIA","family":"FATINI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"VERONICA","family":"ROGAI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MARINA","family":"CINELLI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ELENA","family":"STICCHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ROSANNA","family":"ABBATE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MARCO MATUCCI","family":"CERINIC","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,6,30]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-857X(05)70295-7"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002281-199711000-00011"},{"key":"e_1_2_7_4_2","first-page":"428","article-title":"Angiotensin converting enzyme: an in vivo marker of endothelial injury","volume":"120","author":"Matucci Cerinic M.","year":"1992","journal-title":"J. Lab. Clin. Med"},{"key":"e_1_2_7_5_2","first-page":"347","article-title":"Discrepant expression of neprilysin on fibroblasts in diffuse systemic sclerosis","volume":"26","author":"Matucci\u2010Cerinic M.","year":"1999","journal-title":"J. Rheumatol"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-113-5-352"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199305000-00001"},{"key":"e_1_2_7_8_2","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1055\/s-0037-1614864","article-title":"The effects of angiotensin metabolites on the regulation of coagulation and fibrinolysis in cultured rat aortic endothelial cells","volume":"82","author":"Nishimura H.","year":"1999","journal-title":"Thromb. Haemost"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000119190.06968.f1"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-2828(92)91103-C"},{"key":"e_1_2_7_11_2","first-page":"H1471","article-title":"Identification and antisense inhibition of a renin\u2010angiotensin system in transgenic cardiomyocytes","volume":"268","author":"Cook J.L.","year":"1995","journal-title":"Am. J. Physiol"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.1989.256.5.C987"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.87.5.e1"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-003-0069-y"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-3848(02)00056-7"},{"key":"e_1_2_7_16_2","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1096\/fj.03-0727fje","article-title":"Combined effect of bradykinin B2 and neurokinin\u20101 receptor activation on endothelial cell proliferation in acute synovitis","volume":"18","author":"Seegers H.C.","year":"2004","journal-title":"FASEB J"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.99.15.2034"},{"key":"e_1_2_7_18_2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0031-6997(24)01434-0","article-title":"Molecular and cellular mechanisms of angiotensin II\u2010mediated cardiovascular and renal diseases","volume":"52","author":"Kim S.","year":"2000","journal-title":"Pharmacol. Rev"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1210\/me.14.1.99"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1210\/me.10.3.252"},{"key":"e_1_2_7_21_2","first-page":"S162","article-title":"Regulation of renin secretion by angiotensin II\u2010AT1 receptors","volume":"10","author":"Kurtz A.","year":"1999","journal-title":"J. Am. Soc. Nephrol"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2000.102901"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.86.12.1187"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200001203420301"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08089-3"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198706043162301"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199108013250501"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(97)00750-9"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.95.5.1115"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/biof.5520110404"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M200355200"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000107195.13573.E4"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197810192991607"},{"key":"e_1_2_7_34_2","first-page":"1417","article-title":"Reversal of vascular and renal crises of scleroderma by oral angiotensin\u2010converting\u2010enzyme blockade","volume":"300","author":"Lopez\u2010Ovejero J.A.","year":"1979","journal-title":"Am. J. Med"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780250301"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.102.5.1407"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.1991.tb00432.x"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1990.61"},{"key":"e_1_2_7_39_2","first-page":"358","article-title":"Prostaglandin E1 restores the levels of vWF and ACE in chronic critical limb ischemia in systemic sclerosis","volume":"19","author":"Pignone A.","year":"2001","journal-title":"Clin. Exp. Rheumatol"},{"key":"e_1_2_7_40_2","first-page":"428","article-title":"Angiotensin converting enzyme: an in vivo marker of endothelial injury","volume":"120","author":"Matucci Cerinic M.","year":"1992","journal-title":"J. Lab. Clin. Med"},{"key":"e_1_2_7_41_2","first-page":"328","article-title":"Reduced angiotensin converting enzyme plasma activity in scleroderma: a marker of endothelial injury?","volume":"17","author":"Matucci\u2010Cerinic M.","year":"1990","journal-title":"J. Reumatol"},{"key":"e_1_2_7_42_2","article-title":"Angiotensin 1\u20107 in systemic sclerosis: a potential key molecule in the pathogenesis of endothelial dysfunction","author":"Pignone A.","year":"2006","journal-title":"Clin. Exp. Rheumatol"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/16.suppl_1.22"},{"key":"e_1_2_7_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2004.12.018"},{"key":"e_1_2_7_45_2","doi-asserted-by":"publisher","DOI":"10.1136\/mp.55.1.29"},{"key":"e_1_2_7_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(02)01069-0"},{"key":"e_1_2_7_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2004.04.004"},{"key":"e_1_2_7_48_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114844"},{"key":"e_1_2_7_49_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-004-1136-4"},{"key":"e_1_2_7_50_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199917040-00013"},{"key":"e_1_2_7_51_2","unstructured":"Guiducci S. A.Georgountzos C.Fatini et al.Etrurians vs. Greeks: shadows on the role of ACE I\/D polymorphism in systemic sclerosis. Submitted for publication."},{"key":"e_1_2_7_52_2","first-page":"908","article-title":"Polymorphism of endothelial nitric synthase and angiotensin converting enzyme in systemic sclerosis","volume":"117","author":"Assassi S.","year":"2005","journal-title":"Am. J. Med"}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1196%2Fannals.1351.002","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1196\/annals.1351.002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:16:05Z","timestamp":1736468165000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1196\/annals.1351.002"}},"subtitle":["From Endothelial Injury to a Genetic Polymorphism"],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["10.1196\/annals.1351.002"],"URL":"https:\/\/doi.org\/10.1196\/annals.1351.002","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"type":"print","value":"0077-8923"},{"type":"electronic","value":"1749-6632"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}